Metraipolis › archive › dc_9e6d60e47bd2

Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Europe PMC PMID:41694088

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41694088
DOI
10.1002/jha2.70243
License (as archived)
solo-consultazione
Archived
2026-11-05T21:44:53.962Z
SHA-256 of the archived text
ff5080c7df9b91c0bb7a274777df53791998fc0e65599a61a327db60d77316bc
Stable URL of this page
https://metraipolis.com/documento/dc_9e6d60e47bd2

How to cite

Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Europe PMC PMID:41694088 — Europe PMC (en), https://europepmc.org/article/MED/41694088 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9e6d60e47bd2 (Metraipolis archive dc_9e6d60e47bd2, sha256 ff5080c7df9b91c0bb7a274777df53791998fc0e65599a61a327db60d77316bc)
BibTeX
@misc{dc9e6d60e47bd2,
  title = {Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Europe PMC PMID:41694088},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41694088},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9e6d60e47bd2; sha256 ff5080c7df9b91c0bb7a274777df53791998fc0e65599a61a327db60d77316bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41694088. Agents can read the archived copy with the MCP tool read_document.